Rami Salih Gabani

Rami Salih Gabani

Auto-generated profile, based on publicly available information

Rami Salih Gabani

Hospital Clinic de Barcelona, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2022 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
FSFrancesco Spione
Francesco Spione
VAVictor Arévalos
Victor Arévalos
RGRami Gabani
Rami Gabani
LOLuis Ortega-Paz
Luis Ortega-Paz
JGJosep Gomez‐Lara
Josep Gomez‐Lara
SBSalvatore Brugaletta
Salvatore Brugaletta
Background: Long‐term outcomes of ST‐segment–elevation myocardial infarction in patients with diabetes have been barely investigated. The objective of this analysis from the EXAMINATION‐EXTEND (10‐Years Follow‐Up of the EXAMINATION trial) trial was to compare 10‐year outcomes of patients with ST‐segment–elevation myocardial infarction with and without diabetes. Methods and Results: Of the study population, 258 patients had diabetes and 1240 did not. The primary end point was patient‐oriented composite end point of all‐cause death, any myocardial infarction, or any revascularization. Secondary end points were the individual components of the primary combined end point, cardiac death, target vessel myocardial infarction, target lesion revascularization, and stent thrombosis. All end points were adjusted for potential confounders. At 10 years, patients with diabetes showed a higher incidence of patient‐oriented composite end point compared with those without (46.5% versus 33.0%; adjusted hazard ratio [HR], 1.31 [95% CI, 1.05–1.61]; P =0.016) mainly driven by a higher incidence of any revascularization (24.4% versus 16.6%; adjusted HR, 1.61 [95% CI, 1.19–2.17]; P =0.002). Specifically, patients with diabetes had a higher incidence of any revascularization during the first 5 years of follow‐up (20.2% versus 12.8%; adjusted HR, 1.57 [95% CI, 1.13–2.19]; P =0.007) compared with those without diabetes. No statistically significant differences were found with respect to the other end points. Conclusions: Patients with ST‐segment–elevation myocardial infarction who had diabetes had worse clinical outcome at 10 years compared with those without diabetes, mainly driven by a higher incidence of any revascularizations in the first 5 years. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04462315.


1 October 2022 in European Heart Journal
Verified
Journal Article
Open access
PDF file
RGR Gabani
R Gabani
FSFrancesco Spione
Francesco Spione
VAVictor Arévalos
Victor Arévalos
LOL Ortega
L Ortega
SBSalvatore Brugaletta
Salvatore Brugaletta
PJPilar Jiménez-Quevedo
Pilar Jiménez-Quevedo
Background: Short-term outcomes of women following STEMI are worse than men, with specifically a higher mortality rate. However, it is unknown if gender may play a role in long-term outcomes. We aim to assess whether very long-term outcomes following STEMI treatment may be still influenced by gender. Methods: The EXAMINATION-EXTEND study was an investigator-driven 10-year follow-up of the EXAMINATION trial, which randomly 1:1 assigned 1498 STEMI patients to receive either EES (n=751) or bare metal stent (BMS) (n=747). This is a sub-analysis of this study, according to gender. Primary endpoint was the composite patient-oriented endpoint (POCE, all-cause death, any myocardial infarction, or any revascularization) at 10-year. Secondary endpoints were individual components of the primary endpoint. All the endpoints were adjusted for age. Results: Out of 1498 STEMI patient, 254 (17%) were women. Overall, women were older, with more arterial hypertension and less smoking history than men. At 10-year, no difference was observed between women and men in terms of POCE (40.6% vs. 34.2%; adjusted hazard ratio (HR) 95% confidence interval [CI]1.14 [0.91–1.42], p=0.259). There was a trend toward a higher all-cause death in women vs. men (27.6%, vs. 19.4%; adjusted HR [95% CI] 1.30 [0.99–1.71], p=0.063), without difference in cardiac death. No differences were present in terms of the other endpoints. Conclusions: At very long-term follow-up there were no differences in the combined patient-oriented endpoint between women and men, with a trend towards a higher all-cause death in women. These findings may suggest that very long-term healthcare attention following STEMI in women should go beyond reduction of cardiac events. Funding Acknowledgement: Type of funding sources: Public hospital(s). Main funding source(s): Public hospital

8 August 2022 in Cardiovascular Revascularization Medicine
Verified
Journal Article
Closed access
RGRami Salih Gabani
Rami Salih Gabani
SBSalvatore Brugaletta
Salvatore Brugaletta
FSFrancesco Spione
Francesco Spione